Custom Sourcing News
Related Searches:
Filter by:
August 5, 2011
ICIG division to supply API from Colorado facility
Read More »
July 27, 2011
Synthesis sites in France, Bahamas pass muster
Read More »
May 12, 2011
Pre-Approval Inspection leads to commercial API launch
Read More »
December 8, 2009
PDS is expanding its team of associates to meet growing demand for API auditing capability.
Read More »
August 17, 2009
Cellceutix Corp. has signed an agreement with Girindus America, Inc. for the manufacture of Kevetrin API.
Read More »
May 21, 2009
Asymchem Laboratories has opened its HPAPI and Drug Product facility in TEDA Tianjin, China.
Read More »
December 11, 2008
Hovione has agreed to acquire Pfizer's Loughbeg Active Pharmaceutical Ingredients (API) site in Cork, Ireland. This site manufactures intermediates for Lipitor's API. The deal is scheduled to be completed by early April 2009. Hovione Cork will employ…
Read More »
September 4, 2008
SAFC Pharma, a member of the Sigma-Aldrich Group, plans a $30 million expansion to its Madison, WI facility to increase its capacity to produce commercial scale High Potency Active Pharmaceutical Ingredients (HPAPIs). The investment includes the purc…
Read More »
April 1, 2008
Dr. Reddy’s Laboratories has entered into a definitive agreement with The Dow Chemical Company to acquire a portion of the Dowpharma Small Molecules business associated with sites in Mirfield and Cambridge, UK.
The acquisition will include…
Read More »
March 7, 2008
Hovione has purchased 75% of Hisyn Pharmaceutical Co. Ltd. The acquisition "provides Hovione with significant drug substance manufacturing production capacity and strengthens its 20-year presence in China," according to a company statement.…
Read More »
February 6, 2008
Alpharma Inc. has announced plans to sell its API business to 3i, a global private equity and venture capital company, for $395 million in cash.
Alpharma's API business develops, manufactures and markets a line of fermentation-based APIs and one c…
Read More »
February 4, 2008
AMRI has purchased FineKem Laboratories Pvt. Ltd., a manufacturing facility located in Aurangabad, India. This acquisition will add to the company’s ability to make custom pilot scale intermediates in India, which is expected to begin 2Q2008, a…
Read More »
February 1, 2008
Albemarle Corp. has entered into a manufacturing agreement with Anthera Pharmaceuticals in preparation for the Phase III trial of Varespladib (A-002), a potential new, oral anti-inflammatory drug for treating preconditions that can lead to heart dise…
Read More »
January 15, 2008
Lanxess Corp. has established a new site in Redmond, WA, to serve the pharmaceutical business line of its affiliate, Saltigo GmbH (a subsidiary of Lanxess Deutschland GmbH). The site includes offices, labs and technical facilities and provides Saltig…
Read More »
January 7, 2008
Hikal Ltd. has entered a contract manufacturing agreement to supply Pfizer with API’s. Terms of the agreement were not disclosed.
"We are extremely pleased to be selected as a long-term contract manufacturer by Pfizer…
Read More »
